Table 1 Characteristics of subjects according to body mass index and metabolic health status.
From: Obesity, metabolic health, and urological disorders in adults: a nationwide population-based study
MHNO | MUNO | MHO | MUO | |
|---|---|---|---|---|
N (%) | 2,227,856 (57.4%) | 375,836 (9.7%) | 693,078 (17.9%) | 582,679 (15.0%) |
Age | ||||
Mean ± SD | 43.4 ± 13.8 | 56.5 ± 12.8 | 44 ± 12.5 | 51.3 ± 13.2 |
20–39 | 937,385 (42.08) | 38,073 (10.13) | 271,340 (39.15) | 122,878 (21.09) |
40–64 | 1,096,397 (49.21) | 229,140 (60.97) | 373,469 (53.89) | 355,449 (61) |
65- | 194,074 (8.71) | 108,623 (28.9) | 48,269 (6.96) | 104,352 (17.91) |
Sex, male | 1,273,955 (57.18) | 227,874 (60.63) | 485,548 (70.06) | 397,568 (68.23) |
Height | 164.9 ± 8.9 | 162.7 ± 9.5 | 166.1 ± 9.3 | 165.1 ± 9.8 |
Weight | 59.5 ± 8.7 | 60.9 ± 8.6 | 74.2 ± 9.6 | 76.2 ± 11.3 |
Body mass index | 21.8 ± 2 | 22.9 ± 1.6 | 26.8 ± 1.9 | 27.9 ± 2.4 |
Systolic blood pressure | 118.7 ± 13.8 | 130.9 ± 15.1 | 123.4 ± 13.4 | 132.3 ± 14.6 |
Diastolic blood pressure | 74.2 ± 9.4 | 80.5 ± 10.1 | 77.4 ± 9.3 | 82.3 ± 10.1 |
Glucose | 92.3 ± 17.6 | 113.2 ± 36.5 | 93.3 ± 16.2 | 110.3 ± 32.1 |
Total cholesterol | 189 ± 37.4 | 202.5 ± 51.4 | 200.1 ± 37.4 | 206.6 ± 47.3 |
Family history | ||||
Hypertension | 199,757 (13.54) | 44,390 (18.49) | 71,461 (15.2) | 79,244 (20.34) |
Diabetes mellitus | 165,645 (11.23) | 34,963 (14.57) | 61,074 (13) | 59,285 (15.23) |
Heart disease | 65,594 (4.45) | 11,964 (4.99) | 22,121 (4.71) | 20,522 (5.28) |
Stroke | 108,378 (7.35) | 25,407 (10.59) | 37,714 (8.03) | 38,775 (9.96) |
Smoke | ||||
Non | 1,287,574 (57.79) | 205,526 (54.69) | 346,521 (50) | 288,227 (49.47) |
Ex | 291,489 (13.08) | 64,133 (17.06) | 122,202 (17.63) | 112,755 (19.35) |
Current | 648,793 (29.12) | 106,177 (28.25) | 224,355 (32.37) | 181,697 (31.18) |
Drink | ||||
Non | 1,059,652 (47.56) | 204,121 (54.31) | 295,215 (42.59) | 273,198 (46.89) |
1–2 times/week | 876,133 (39.33) | 104,810 (27.89) | 295,771 (42.67) | 204,870 (35.16) |
≥ 3 times/week | 292,071 (13.11) | 66,905 (17.8) | 102,092 (14.73) | 104,611 (17.95) |
Exercise | ||||
Non | 1,081,004 (48.52) | 196,342 (52.24) | 298,217 (43.03) | 281,384 (48.29) |
1–4 times/week | 958,727 (43.03) | 138,788 (36.93) | 328,435 (47.39) | 245,101 (42.06) |
≥ 5 times/week | 188,125 (8.44) | 40,706 (10.83) | 66,426 (9.58) | 56,194 (9.64) |
Income, lower 20% | 390,329 (17.52) | 65,640 (17.47) | 118,014 (17.03) | 95,804 (16.44) |
Hypertension | 340,824 (15.3) | 237,933 (63.31) | 151,406 (21.85) | 355,796 (61.06) |
Code/medication | 213,568 (9.59) | 190,077 (50.57) | 88,996 (12.84) | 262,509 (45.05) |
Lab | 186,127 (8.35) | 106,218 (28.26) | 92,021 (13.28) | 188,540 (32.36) |
Diabetes | 71,148 (3.19) | 98,832 (26.3) | 22,823 (3.29) | 132,325 (22.71) |
Code/medication | 37,074 (1.66) | 71,492 (19.02) | 10,531 (1.52) | 86,823 (14.9) |
Lab | 54,375 (2.44) | 67,431 (17.94) | 18,032 (2.6) | 93,824 (16.1) |
Dyslipidemia | 174,264 (7.82) | 174,328 (46.38) | 87,648 (12.65) | 226,505 (38.87) |
Code/medication | 23,925 (1.07) | 141,558 (37.66) | 6,312 (0.91) | 153,472 (26.34) |
Lab | 162,182 (7.28) | 69,364 (18.46) | 84,245 (12.16) | 111,280 (19.1) |
